APR 07, 2016 10:17 AM PDT

New Computer Tool Tailors Drug Dosing for Patients

WRITTEN BY: Julianne Chiaet
This image represents a compilation of schematic, patient-specific, parabolic response surfaces, which are the keys to personalized medicine. They represent responses to combination therapy for individual patients for liver transplant immunosuppression.
How much medication should you be prescribed? Everyone is born with a different body, so how much and what kind of medication needs to be tailored to you. 

For instance, after a patient has received an organ transplant, they are at risk of their body rejecting the new organ. To combat this, doctors heavily treat the patient using immunosuppressive drugs. 
 
Immunosuppressive drugs have a narrow therapeutic range. If the dose is too high, it is toxic. If the dose is too low, it could fail to keep the body from rejecting the organ. Clinicians keep a close eye on their patients and make decisions about adjusting the dose according to how they are responding the drugs. They additionally decide whether the patient needs additional medications or therapies, such as dialysis. They ultimately consider a plethora of factors before deciding on their patient’s prescription regime.  

But, when it comes down to it, those “decisions” are actually educated guesses. Doctors can’t be 100 percent sure how a patient’s body will react. After all, a patient’s ethnicity, age, genetics, and comorbidity all affect how they respond to a medication. 
 

Now, a pilot study has demonstrated the effectiveness of a computational tool that could take the guesswork out of prescribing medications for immunosuppression, cancer, heart disease, bacterial infections, and other conditions that require tightly controlled treatment regimens. The research was published on April 6, 2016, in the journal Science Translational Medicine.

The tool, called parabolic personalized dosing (PPD), uses a mathematical approach to predict the next best dose of a drug for an individual. It harnesses a patient’s clinical data, such as the drug concentration in the bloodstream, to predict the next ideal dose per patient. PPD is different from other approaches based on mathematical modeling in that it uses an algebraic equation to build a parabolic map of the patient’s response to a drug. 

In the pilot trial, UCLA researchers treated four liver transplant patients with immunosuppressant drugs using doses determined by PPD. Another group was prescribed immunosuppressant drugs using standard physician-guided dosing. The patients guided by PPD stayed within the target drug dosing range more frequently than the latter group. The PPD patients also tended to have shorter hospital stays. 

The trial showed PPD also has the potential to optimize dosing for patients using a combination of drugs. The researchers hope clinicians will use PPD in the future to automatically tailor drug dosing for a wide range of patients, including those with cancer and heart disease. 
About the Author
  • Julianne (@JuliChiaet) covers health and medicine for LabRoots. Her work has been published in The Daily Beast, Scientific American, and MailOnline. While primarily a science journalist, she has also covered culture and Japanese organized crime. She is the New York Board Representative for the Asian American Journalists Association (AAJA). • To read more of her writing, or to send her a message, go to Jchiaet.com
You May Also Like
OCT 01, 2020
Cardiology
Investigating Inflammation in Coronary Artery Bypass Grafts
OCT 01, 2020
Investigating Inflammation in Coronary Artery Bypass Grafts
The heart is a vital part of the body that can last one hundred years, yet even a small change can cause massive consequ ...
OCT 04, 2020
Microbiology
A Virus Can Disrupt a Carb-Consuming Gut Microbe
OCT 04, 2020
A Virus Can Disrupt a Carb-Consuming Gut Microbe
Not all viruses affect animal cells; some viruses can infect bacteria. Humans are known to carry vast numbers of microor ...
OCT 04, 2020
Cardiology
The Genetics of Body Fat May Shape Health Risks
OCT 04, 2020
The Genetics of Body Fat May Shape Health Risks
The work may help explain why men and women are at risk for different diseases and often respond to different treatments ...
OCT 07, 2020
Genetics & Genomics
Researchers Confirm Cerebral Palsy Has a Genetic Component
OCT 07, 2020
Researchers Confirm Cerebral Palsy Has a Genetic Component
Scientists have confirmed previous studies that have suggested that some cases of cerebral palsy are due to a genetic mu ...
OCT 29, 2020
Clinical & Molecular DX
More Frequent Trips to the Pediatrician Linked to a Future Autism Diagnosis
OCT 29, 2020
More Frequent Trips to the Pediatrician Linked to a Future Autism Diagnosis
 
OCT 25, 2020
Cell & Molecular Biology
Revealing More About the Genetics of Ewing Sarcoma
OCT 25, 2020
Revealing More About the Genetics of Ewing Sarcoma
Ewing sarcoma is a rare kind of cancer that tends to impact young people and occurs in bones or the tissue around them. ...
Loading Comments...